Randomized controlled phase III trial of adjuvant chemo-immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancer

PURPOSE: We conducted a phase III randomized controlled trial (RCT) to investigate the efficacy of postsurgical adjuvant immunotherapy combined with chemotherapy. The immunotherapy targets were residual micrometastases and clones resistant to chemotherapy. PATIENTS AND METHODS: Between April 2007 an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura, Hideki, Matsui, Yukiko, Ishikawa, Aki, Nakajima, Takahiro, Yoshino, Mitsuru, Sakairi, Yuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282697/
https://www.ncbi.nlm.nih.gov/pubmed/25262164
http://dx.doi.org/10.1007/s00262-014-1613-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282697/
https://www.ncbi.nlm.nih.gov/pubmed/25262164
http://dx.doi.org/10.1007/s00262-014-1613-0

Ejemplares similares